Herpes vaccine trials end due to failure

September 30, 2010 5:38:55 PM PDT
A test trial for an experimental vaccine to treat genital herpes in women has ended in disappointment.

Glaxo-Smith-Kline announced it is abandoning the vaccine, after spending millions of dollars in trials and development.

A final assessment showed that while it did not harm the women and it was also not effective.